Skip to content Skip to footer
Our mission

Saving lives and improving health through life technologies

Who We Are

CrossLife Technologies is a life sciences company founded with the mission of alleviating suffering and improving health through the development and commercialization of innovative molecular diagnostics for infectious diseases and non-communicable diseases. We are focused on discovering, developing and commercializing innovative DNA/RNA based diagnostic technologies and products. 

The company was formed in 2010 and the management team consists of experienced diagnostic kit & test development personnel. We are committed to improving the quality of healthcare worldwide by providing high quality, reliable, cutting-edge tools for molecular diagnostics. We will achieve this by developing new technologies, complying with government regulations, maintaining an effective quality program, and utilizing customer feedback to improve our products and processes.

Big achievements 1

Where We Excel:

RNA/DNA Molecular Diagnostics

This innovative approach to disease detection uses genetic material analysis to precisely identify markers and biomarkers. 

Point-of-Care Diagnostics

It offers rapid and convenient testing, providing immediate results without relying on laboratories. 

Infectious Disease Detection

Rapid and accurate identification of infectious diseases is vital for effective control and prevention. 

Cancer Diagnostics

Diagnostic methods identify tumors and assess their characteristics for precise diagnosis and treatment planning.

developing and commercializing


We are dedicated to developing and commercializing novel diagnostics based on innovative nucleic acid technologies for many diseases.  

Big achievements 2

Key Differentiators

Minimal sample preparation

Minimal sample preparation streamlines testing by minimizing steps and reducing turnaround time. This approach is particularly beneficial for rapid diagnostics and point-of-care testing.

Amplification without PCR

This refers to alternative methods for efficiently amplifying nucleic acid sequences without using traditional PCR techniques. These innovative approaches offer accelerated and streamlined molecular diagnostics.

Low cost

Affordable options in various fields, including healthcare. In diagnostics, these solutions provide accessible and cost-effective tools and tests without compromising quality. They ensure that essential healthcare services are available to all.


Point-of-Care testing allows for convenient and immediate testing at the patient’s location, eliminating the need for laboratory processing.

Innovation and Impact


Our supporters are part of our journey towards making a meaningful difference. Together, we drive innovation, foster excellence, and create a lasting impact in science, technology, and healthcare.

Go To Top

Subscribe to the